Biotech Development Technical Review 
Crunchbase News
NOVEMBER 1, 2024
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. tied) Insider , $500M, digital marketing: Marketing tech platform Insider raised a $500 million Series E led by General Atlantic to fund its expansion in the U.S.
TechCrunch
OCTOBER 28, 2022
In a previous era, aspiring journalists relocated to New York, would-be actors made pilgrimages to Hollywood and plucky tech founders moved to the Bay Area so they could attract capital and talent. A prep checklist for startups about to undergo technical due diligence. Development process. Budding Biotech.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
DECEMBER 15, 2022
That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.
Crunchbase News
DECEMBER 3, 2024
Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.
TechCrunch
MARCH 24, 2021
Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. LiliumX is taking the algorithmic approach to generating potential antibody stuctures that could be effective, as many AI-informed biotech companies have before it. Startups take on big pharma.
Crunchbase News
MARCH 4, 2025
In fact, it took $200 million or more to make the list last month, as defense tech and cybersecurity led the way. Lambda is also a provider of the latest GPUs by Nvidia , which are highly sought after by AI developers. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025.
Crunchbase News
NOVEMBER 22, 2024
To a great degree, the largest rounds of the year went to a handful of AI companies working on large language models and underlying technologies to scale them. While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns. billion in all of 2023.
Expert insights. Personalized for you.
129 
Let's personalize your content